What is Vivos's earnings per share (EPS)?

Vivos (RDGL) reported diluted earnings per share of $-0.01 for fiscal year 2025. This represents a 0.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Vivos Financials

RDGL

Source SEC Filings (10-K/10-Q) Updated Mar 30, 2026 Currency USD FYE March

This page shows Vivos (RDGL) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Earnings Quality Low Quality

0.67x

For every $1 of reported earnings, Vivos generates $0.67 in operating cash flow (-$2.1M OCF vs -$3.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

-32.0x

Vivos earns $-32.0 in operating income for every $1 of interest expense (-$3.2M vs $99K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$68K

YoY+144.3%

5Y CAGR+57.7%

10Y CAGR+11.0%

Vivos generated $68K in revenue in fiscal year 2025. This represents an increase of 144.3% from the prior year.

EBITDA

-$3.2M

Vivos's EBITDA was -$3.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Net Income

-$3.1M

YoY-5.3%

Vivos reported -$3.1M in net income in fiscal year 2025. This represents a decrease of 5.3% from the prior year.

EPS (Diluted)

$-0.01

YoY+0.0%

Vivos earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Cash & Balance Sheet

Free Cash Flow

-$2.2M

Vivos generated -$2.2M in free cash flow in fiscal year 2025, representing cash available after capex.

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

483M

YoY+9.5%

5Y CAGR+10.6%

Vivos had 483M shares outstanding in fiscal year 2025. This represents an increase of 9.5% from the prior year.

Margins & Returns

Gross Margin

-87.4%

YoY-76.7pp

5Y CAGR-107.3pp

10Y CAGR-185.4pp

Vivos's gross margin was -87.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 76.7 percentage points from the prior year.

Operating Margin

-4628.7%

YoY+4674.3pp

5Y CAGR+4978.8pp

10Y CAGR+3838.5pp

Vivos's operating margin was -4628.7% in fiscal year 2025, reflecting core business profitability. This is up 4674.3 percentage points from the prior year.

Net Margin

-4483.9%

YoY+5912.4pp

5Y CAGR+9187.4pp

10Y CAGR-30337.0pp

Vivos's net profit margin was -4483.9% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5912.4 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$352K

YoY+8.5%

5Y CAGR+33.0%

10Y CAGR+8.9%

Vivos invested $352K in research and development in fiscal year 2025. This represents an increase of 8.5% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$103K

Vivos invested $103K in capex in fiscal year 2025, funding long-term assets and infrastructure.

RDGL Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$68K+144.3%	$28K+43.6%	$20K-46.6%	$36K+145.2%	$15K+112.7%	$7K
Cost of Revenue	$128K+313.6%	$31K+21.3%	$26K-11.3%	$29K+139.8%	$12K+114.0%	$6K
Gross Profit	-$60K-1902.5%	-$3K+50.6%	-$6K-178.2%	$8K+167.4%	$3K+107.4%	$1K
R&D Expenses	$352K+8.5%	$325K-55.7%	$733K+113.1%	$344K+19.9%	$287K+238.8%	$85K
SG&A Expenses	$297K+22.6%	$242K+45.9%	$166K+9.7%	$151K+34.9%	$112K+2.8%	$109K
Operating Income	-$3.2M-21.5%	-$2.6M+6.8%	-$2.8M-10.9%	-$2.5M-0.6%	-$2.5M-272.0%	-$673K
Interest Expense	$99K+32.2%	$75K+51.2%	$50K	N/A	$25K-91.2%	$287K
Income Tax	N/A	N/A	N/A	N/A	$0	$0
Net Income	-$3.1M-5.3%	-$2.9M-0.5%	-$2.9M-17.2%	-$2.5M+2.3%	-$2.5M-164.1%	-$957K
EPS (Diluted)	$-0.010.0%	$-0.010.0%	$-0.010.0%	$-0.01	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$2K-87.5%	$15K-43.9%	$27K+435.5%	$5K-0.1%	$5K-63.0%	$14K+200.0%	$5K	$0
Cost of Revenue	$15K-70.5%	$50K+38.9%	$36K+248.6%	$10K+162.3%	$4K-63.6%	$11K+79.7%	$6K	N/A
Gross Profit	-$13K+63.1%	-$35K-282.6%	-$9K-71.9%	-$5K-588.9%	$1K-60.3%	$3K+281.3%	-$2K+83.3%	-$9K
R&D Expenses	$68K-37.2%	$108K-9.5%	$119K+18.1%	$101K+51.7%	$67K-33.2%	$100K+73.5%	$57K-86.7%	$432K
SG&A Expenses	$73K-9.9%	$81K+55.0%	$52K-46.9%	$98K+51.0%	$65K+18.6%	$55K+134.5%	$23K-28.9%	$33K
Operating Income	-$531K+21.3%	-$675K+21.9%	-$864K-30.5%	-$662K+21.5%	-$843K-61.4%	-$522K+9.5%	-$577K+38.8%	-$943K
Interest Expense	$24K-18.9%	$29K+1.5%	$29K+47.0%	$20K+9.7%	$18K-5.1%	$19K+1.4%	$19K	N/A
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$507K+21.4%	-$646K+22.7%	-$835K+18.4%	-$1.0M-24.0%	-$825K-63.9%	-$503K+9.9%	-$559K+48.1%	-$1.1M
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

RDGL Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	N/A	$2.2M+38.7%	$1.6M-7.6%	$1.7M+6.6%	$1.6M+74.3%	$938K
Current Assets	N/A	$2.2M+38.7%	$1.6M-7.6%	$1.7M+6.6%	$1.6M+74.3%	$938K
Cash & Equivalents	N/A	$2.2M+39.0%	$1.6M-6.7%	$1.7M+6.2%	$1.6M+77.7%	$904K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	$10K+47.5%	$7K-36.4%	$11K	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	N/A	$86K-64.8%	$245K+199.9%	$82K-51.1%	$167K-81.6%	$906K
Current Liabilities	N/A	$86K-64.8%	$245K+199.9%	$82K-51.1%	$167K-81.6%	$906K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	N/A	$2.1M+57.3%	$1.4M-17.8%	$1.7M+13.2%	$1.5M+4480.7%	$32K
Retained Earnings	N/A	-$85.4M-3.5%	-$82.5M-3.6%	-$79.6M-3.2%	-$77.1M-3.4%	-$74.6M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$2.3M-17.3%	$2.8M-15.9%	$3.3M+47.8%	$2.2M+79.5%	$1.2M-29.7%	$1.8M+28.0%	$1.4M-14.1%	$1.6M
Current Assets	$2.3M-17.3%	$2.8M-15.9%	$3.3M+47.8%	$2.2M+79.5%	$1.2M-29.7%	$1.8M+28.0%	$1.4M-14.1%	$1.6M
Cash & Equivalents	$2.2M-17.2%	$2.7M-18.5%	$3.3M+47.6%	$2.2M+81.6%	$1.2M-29.4%	$1.7M+25.8%	$1.4M-13.9%	$1.6M
Inventory	$63K-0.4%	$63K+197.0%	$21K	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$5K-64.6%	$13K+52.5%	$9K-15.7%	$10K+106.5%	$5K-63.0%	$14K+17.4%	$12K+64.3%	$7K
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$113K+16.8%	$96K-16.4%	$115K+33.8%	$86K+76.6%	$49K-70.7%	$167K+122.8%	$75K-69.5%	$245K
Current Liabilities	$113K+16.8%	$96K-16.4%	$115K+33.8%	$86K+76.6%	$49K-70.7%	$167K+122.8%	$75K-69.5%	$245K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$2.2M-18.5%	$2.7M-15.9%	$3.2M+48.4%	$2.1M+79.6%	$1.2M-25.4%	$1.6M+22.6%	$1.3M-4.2%	$1.4M
Retained Earnings	-$87.3M-0.6%	-$86.8M-0.7%	-$86.2M-1.0%	-$85.4M-1.2%	-$84.3M-1.0%	-$83.5M-0.6%	-$83.0M-0.7%	-$82.5M

RDGL Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	-$2.1M-22.2%	-$1.7M-30.2%	-$1.3M-15.4%	-$1.1M-16.2%	-$964K-10.0%	-$876K
Capital Expenditures	$103K	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	-$2.2M	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	-$103K	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$1.5M-34.6%	$2.3M+95.4%	$1.2M-3.3%	$1.2M-26.8%	$1.7M-5.3%	$1.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$458K+24.2%	-$605K-32.8%	-$455K+3.3%	-$471K+7.0%	-$506K-42.4%	-$355K-1.1%	-$351K+24.1%	-$463K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$0	$0-100.0%	$1.5M+2.9%	$1.5M	$0-100.0%	$709K+445.4%	$130K-74.9%	$519K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

RDGL Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	-87.4%-76.7pp	-10.7%+20.3pp	-30.9%-52.1pp	21.1%+1.8pp	19.4%-0.5pp	19.9%
Operating Margin	-4628.7%+4674.3pp	-9303.0%+5020.8pp	-14323.8%-7425.7pp	-6898.1%+9907.1pp	-16805.3%-7197.8pp	-9607.4%
Net Margin	-4483.9%+5912.4pp	-10396.3%+4448.6pp	-14844.9%-8077.1pp	-6767.7%+10211.9pp	-16979.7%-3308.4pp	-13671.3%
Return on Equity	N/A	-135.5%+76.5pp	-212.0%-63.3pp	-148.7%+23.5pp	-172.3%+2815.2pp	-2987.4%
Return on Assets	N/A	-130.3%+49.5pp	-179.8%-38.0pp	-141.7%+12.9pp	-154.7%-52.6pp	-102.1%
Current Ratio	N/A	25.91+19.3	6.57-14.8	21.33+11.5	9.79+8.8	1.04
Debt-to-Equity	N/A	0.04-0.1	0.18+0.1	0.05-0.1	0.11-28.2	28.27
FCF Margin	-3160.2%	N/A	N/A	N/A	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	-682.0%-450.3pp	-231.7%-197.7pp	-34.0%+71.9pp	-105.8%-127.4pp	21.6%+1.5pp	20.2%+53.5pp	-33.3%	N/A
Operating Margin	-28260.9%-23762.5pp	-4498.5%-1270.1pp	-3228.4%+10020.9pp	-13249.3%+3613.6pp	-16862.9%-12993.9pp	-3869.0%+8956.1pp	-12825.1%	N/A
Net Margin	-26998.1%-22694.7pp	-4303.4%-1182.8pp	-3120.6%+17363.7pp	-20484.2%-3979.0pp	-16505.3%-12775.9pp	-3729.3%+8682.7pp	-12412.0%	N/A
Return on Equity	-23.2%+0.9pp	-24.1%+2.1pp	-26.2%+21.5pp	-47.6%+21.4pp	-69.0%-37.6pp	-31.4%+11.3pp	-42.7%+36.1pp	-78.8%
Return on Assets	-22.1%+1.2pp	-23.3%+2.0pp	-25.3%+20.5pp	-45.8%+20.5pp	-66.3%-37.9pp	-28.4%+12.0pp	-40.4%+26.4pp	-66.8%
Current Ratio	20.37-8.4	28.77+0.2	28.62+2.7	25.91+0.4	25.49+14.9	10.62-7.9	18.49+11.9	6.57
Debt-to-Equity	0.05+0.0	0.040.0	0.040.0	0.040.0	0.04-0.1	0.10+0.0	0.06-0.1	0.18
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Acarix AB ACIXF

$33.8M

Theralase Technologies Inc TLTFF

$53.0M

Positron POSC

$53.9M

Cannabix Technol BLOZF

$65.6M

Petvivo Hldgs Inc PETV

$25.0M

Frequently Asked Questions

What is Vivos's annual revenue?

Vivos (RDGL) reported $68K in total revenue for fiscal year 2025. This represents a 144.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Vivos's revenue growing?

Vivos (RDGL) revenue grew by 144.3% year-over-year, from $28K to $68K in fiscal year 2025.

Is Vivos profitable?

No, Vivos (RDGL) reported a net income of -$3.1M in fiscal year 2025, with a net profit margin of -4483.9%.

What is Vivos's EBITDA?

Vivos (RDGL) had EBITDA of -$3.2M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Vivos's gross margin?

Vivos (RDGL) had a gross margin of -87.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Vivos's operating margin?

Vivos (RDGL) had an operating margin of -4628.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Vivos's net profit margin?

Vivos (RDGL) had a net profit margin of -4483.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Vivos's free cash flow?

Vivos (RDGL) generated -$2.2M in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Vivos's operating cash flow?

Vivos (RDGL) generated -$2.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Vivos's capital expenditures?

Vivos (RDGL) invested $103K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Vivos spend on research and development?

Vivos (RDGL) invested $352K in research and development during fiscal year 2025.

How many shares does Vivos have outstanding?

Vivos (RDGL) had 483M shares outstanding as of fiscal year 2025.

Are Vivos's earnings high quality?

Vivos (RDGL) has an earnings quality ratio of 0.67x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Vivos cover its interest payments?

Vivos (RDGL) has an interest coverage ratio of -32.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.